Peptomyc is proud to share this publication in Journal of Controlled Release, result of a collaboration with Vall d'Hebron Institute of Oncology (VHIO), Brunel University London, and University “G. D'Annunzio” of Chieti-Pescara, showing that #Omomyc can be fused to antibodies to optimize tumor targeting.
I am happy to share this recent publication, result of a nice collaboration with Arturo Sala and Gianluca Sala, showing that #Omomyc can be functionalized by fusion with antibodies to favor tumor targeting. https://lnkd.in/dcrmrdA9 Vall d'Hebron Institute of Oncology (VHIO), Institució Catalana de Recerca i Estudis Avançats, ICREA, Peptomyc
Growth Strategy Advisor Europe #SilverEconomy #Biotech
2moCongrats to all the team Laura Soucek Jörg Klumbis